Repatriation Tax Bill Eyed By Device Firms As Opportunity For R&D Windfall
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is rallying the medical technology sector to support legislation (HR 767, S 596) that would lift tax restrictions on repatriation of foreign profits by U.S. firms
You may also be interested in...
Tax Repatriation On Kerry Agenda; Breaux Says Bill Passage Viable This Year
Legislation encouraging med tech companies to transfer overseas cash holdings to the U.S. could pass Congress this year if the bill ensures that proceeds go to new job creation, Sen. John Breaux (D-La.) recently told drug industry reps
Tax Repatriation On Kerry Agenda; Breaux Says Bill Passage Viable This Year
Legislation encouraging med tech companies to transfer overseas cash holdings to the U.S. could pass Congress this year if the bill ensures that proceeds go to new job creation, Sen. John Breaux (D-La.) recently told drug industry reps
Foreign Subsidiary Earnings Bill Headed For Senate Floor? Med Tech On Board
Senate legislation granting firms a one-time tax break on repatriation of overseas income could go to the floor before November adjournment, according to staffers